# PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer

> **NCT02793856** · PHASE1 · COMPLETED · sponsor: **Sichuan University** · enrollment: 12 (actual)

## Conditions studied

- Metastatic Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Cyclophosphamide
- **OTHER:** PD-1 Knockout T Cells

## Key facts

- **NCT ID:** NCT02793856
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-26
- **Primary completion:** 2018-08-20
- **Final completion:** 2020-03-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02793856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02793856, "PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02793856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*